Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,499 public trials 456 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

PKU Skin Stripping

NCT04368624

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +9 more
Locations
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

NCT01415427

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +12 more
Locations
  • Phoenix, Arizona, United States
  • Oakland, California, United States
  • Orange, California, United States
  • Wilmington, Delaware, United States
View all 43 locations
View Trial Details
Completed

This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.

NCT01304277

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
  • The Hospital for Sick Children Toronto, Ontario, Canada
  • INC Research Toronto, Ontario, Canada
View Trial Details
Completed

Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

NCT01431638

Conditions
Acute Gouty Arthritis, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Gulf Shores, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Chandler, Arizona, United States
View all 68 locations
View Trial Details
Completed

Alglucosidase Alfa Pompe Safety Sub-Registry

NCT01710813

Conditions
Anaphylaxis, Brain Diseases, Brain Diseases, Metabolic, +17 more
Locations
  • Investigational Site Number 840016 Phoenix, Arizona, United States
  • Investigational Site Number 840002 Durham, North Carolina, United States
  • Investigational Site Number 840004 Hershey, Pennsylvania, United States
  • Investigational Site Number 840014 Pittsburgh, Pennsylvania, United States
View all 18 locations
View Trial Details

Related conditions